Clinical Study

Thromboelastography to Monitor Clotting/Bleeding Complications in Patients Treated with the Molecular Adsorbent Recirculating System

Figure 3

High plasma fibrinogen concentration and lack of thrombocytopenia at baseline predict clotting within the MARS filter system. (a) Baseline fibrinogen concentrations and platelet counts from individual sessions were grouped into sessions without event (uneventful), complicated by bleeding episodes and complicated by clotting events within the MARS filter system. (b) Receiver operator curve of baseline plasma fibrinogen concentration and platelet count for prediction of MARS filter clotting events. Significant values are indicated, AUCROC = 0.94 (CI95% 0.74 to 0.99) for fibrinogen, 0.82 (CI95% 0.5 to 0.95) for platelets, respectively, sessions analysed ( ), of which ( ) were uneventful, ( ) were complicated by bleeding and ( ) by clotting of the MARS filter system.
313854.fig.003a
(a)
313854.fig.003b
(b)